Stage 3 kidney disease means your kidneys are filtering blood at 30 to 59 percent of normal capacity, measured by a number called eGFR. It’s split into two substages: stage 3a (eGFR 45–59) and stage 3b (eGFR 30–44). The causes range from common chronic conditions like diabetes and high blood pressure to less obvious factors like medication overuse, inherited conditions, and repeated infections.
Diabetes: The Leading Cause
Diabetes is the single most common cause of chronic kidney disease, and it damages the kidneys through a chain reaction that starts with high blood sugar. When blood sugar stays elevated over months and years, glucose molecules attach to proteins, fats, and collagen throughout the body, forming compounds called advanced glycation end products. These modified molecules trigger inflammation, oxidative stress, and abnormal cell growth inside the kidneys’ tiny filtering units.
The damage shows up in specific ways. The membranes that filter your blood thicken. The tissue between the filters accumulates excess material that doesn’t get broken down properly. The small blood vessels inside the kidney widen early on, forcing each filter to work harder than it should. This “hyperfiltration” phase can actually make kidney function look normal or even high at first, which is why diabetes-related kidney damage often goes undetected until it’s well advanced. Over time, the overworked filters scar and fail, and kidney function steadily drops into stage 3 territory and beyond.
High Blood Pressure and Vascular Damage
Sustained high blood pressure is the second most common driver of kidney disease, and it works differently from diabetes. The kidneys depend on a massive network of tiny blood vessels, and chronic hypertension batters these vessels from the inside. The walls of the small arteries feeding the kidneys thicken and stiffen, narrowing the space blood can flow through. Less blood reaching the filters means less oxygen, and the tissue gradually starves.
Initially, the kidneys compensate. Small arteries constrict to shield the delicate filters from the full force of high pressure. But this protection breaks down over time. Some filters lose that buffer entirely, exposing them to damaging pressure levels. Those filters scar. The surviving filters then pick up the extra workload, which causes them to enlarge and eventually scar as well. The result is a slow, compounding loss of filtering capacity. When this process, called nephrosclerosis, affects enough of the kidney, eGFR drops into the stage 3 range.
Narrowing of the main arteries feeding the kidneys, known as renal artery stenosis, can accelerate this process. When one or both renal arteries become partially blocked (usually by the same plaque buildup that causes heart disease), the kidneys don’t receive enough oxygen-rich blood to function properly. This can injure kidney tissue directly and raise blood pressure throughout the body, creating a damaging feedback loop.
Autoimmune and Inflammatory Kidney Disease
The immune system can attack the kidneys directly, and several autoimmune conditions do exactly that. The umbrella term for immune-driven kidney inflammation is glomerulonephritis, and it encompasses a range of diseases that damage the kidney’s filtering membranes through different pathways. In some forms, antibodies latch onto the filter membranes themselves. In others, antibody clusters formed elsewhere in the body get trapped in the kidneys and trigger a local inflammatory response.
Lupus is a major culprit. Lupus nephritis affects 30 to 60 percent of adults with lupus and up to 70 percent of children with the disease. It begins when immune complexes deposit in the kidney filters, recruiting waves of inflammation. Over time, this damages specialized cells called podocytes that are essential for keeping proteins in the blood. As podocytes die off, protein leaks into the urine, and the kidney tissue scars. Even after inflammation resolves, certain changes can reprogram the kidney’s support cells to keep producing scar tissue, making the damage self-sustaining.
IgA nephropathy, another common form, involves a specific antibody (IgA) depositing in the filters and provoking ongoing low-grade inflammation. Some forms of glomerulonephritis progress slowly over years, while others can cause rapid decline. All of them share a common endpoint: scarring that replaces functional tissue and reduces the kidney’s filtering ability.
Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of kidney failure. It works through a “two-hit” mechanism. Every kidney cell in an affected person carries one faulty copy of a gene, but a second random mutation in individual cells is needed to trigger cyst formation. When that second hit occurs, the cell begins dividing uncontrollably, forming a fluid-filled sac that expands relentlessly.
Each cyst acts as an autonomous structure, growing as its lining cells continue to multiply and pump sodium, chloride, and water into its interior. As cysts expand, they compress and destroy the surrounding healthy tissue, trigger inflammation, and attract immune cells that cause further scarring. By the time kidney function starts to decline, the kidneys are usually massively enlarged and distorted, with little visible healthy tissue on imaging. At that point, eGFR typically drops by 4.4 to 5.9 points per year. Most people with ADPKD reach kidney failure between their 40s and 60s, though the timeline varies based on how many cysts form over a lifetime.
Medications and Painkillers
Long-term use of common over-the-counter painkillers, particularly NSAIDs like ibuprofen and naproxen, can cause or accelerate kidney disease. A large study of people with high blood pressure found that those who used NSAIDs for 90 or more days in a year had a 32 percent higher risk of developing chronic kidney disease compared to non-users. Even shorter use (1 to 89 days) raised the risk by 18 percent. Taking more than one standard daily dose pushed the risk up by 23 percent.
NSAIDs reduce blood flow to the kidneys by blocking chemicals that help keep the renal arteries open. In people whose kidneys are already under stress from high blood pressure, diabetes, or aging, this reduction in blood flow can tip the balance from stable function to progressive damage. The risk compounds with higher doses, longer use, and pre-existing kidney vulnerability.
Urinary Tract Obstructions
Anything that blocks the flow of urine out of the kidneys can cause permanent damage if it isn’t resolved. Kidney stones, an enlarged prostate, tumors, and urethral narrowing are the most common culprits. When urine backs up, pressure builds inside the kidney, stretching and compressing the tissue. The kidney initially compensates with changes in blood flow, but if the blockage persists, the tissue begins to die and scar.
Roughly six weeks of unrelieved obstruction is considered the threshold for non-recoverable permanent injury. Collagen and scar tissue replace functional kidney tissue, thinning the outer layer of the kidney where most of the filtering happens. When the blockage affects both kidneys, or when one kidney was already compromised, the result can be a lasting drop in overall kidney function into the stage 3 range or worse.
Recurrent Kidney Infections
Repeated bouts of kidney infection, called pyelonephritis, create a distinctive pattern of scarring. Each infection leaves behind patchy areas of damage in a “jigsaw” pattern, reflecting the irregular way bacteria spread upward through the urinary tract. Over time, the kidney accumulates atrophied tubes, inflammatory tissue, and fibrosis around the filters. When this process, known as chronic pyelonephritis, affects both kidneys, chronic kidney disease typically follows. People with structural abnormalities in their urinary tract, frequent urinary tract infections, or conditions that cause urine to flow backward toward the kidneys are at highest risk.
Aging vs. Disease
Healthy people naturally lose kidney function with age. By their 70s, otherwise healthy individuals have lost roughly half the filtering units they were born with. This normal attrition reduces eGFR gradually, and many older adults end up with an eGFR between 45 and 59 without any actual kidney disease. The key difference is what’s happening at a tissue level. In normal aging, the kidney shrinks modestly but shows minimal scarring, and protein does not leak into the urine. In true kidney disease, there is significant scarring, filter damage, and usually detectable protein in the urine.
This distinction matters because many older adults receive a stage 3a diagnosis based solely on eGFR, when their kidneys are actually aging normally. Experts have argued that CKD diagnostic thresholds should be age-adjusted to avoid mislabeling healthy elderly people. If you’re over 65 with a stable eGFR in the mid-40s to 50s and no protein in your urine, the clinical significance is very different from someone in their 40s with the same numbers. That said, normal aging does make the kidneys more vulnerable to additional insults from medications, dehydration, or new health conditions, so the line between “aging” and “disease” isn’t always sharp.